| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/24/2013 | CN103214489A Multi-target kinase inhibitors with antitumor activities, and preparation method thereof |
| 07/24/2013 | CN103214486A Beta-carboline derivative or medicinal salt as well as preparation method and anti-tumour application thereof |
| 07/24/2013 | CN103214484A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214483A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214482A Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
| 07/24/2013 | CN103214481A Novel imidazo[1,2-a]pyridines compound, preparation method, pharmaceutical composition containing imidazo[1,2-a]pyridines compound and application |
| 07/24/2013 | CN103214480A Pyrazolopyridines alkynylbenzene compound and medicinal composition and application |
| 07/24/2013 | CN103214479A Pyrazole naphthylurea tyrosine kinase inhibitor and its application |
| 07/24/2013 | CN103214472A Preparation of two novel non-ATP (Adenosine Triphosphate) competitive FGFR1 (Fibroblast Growth Factor Receptor1) inhibitors and anti-tumor activity of two novel non-ATP competitive FGFR1 inhibitors |
| 07/24/2013 | CN103214470A Novel anticancer compound synthesized by reaction of ketone and indole derivative |
| 07/24/2013 | CN103214468A Hairpin polyamide modified by chiral (S)-beta-hydroxyl-gamma-amino acid and application for same |
| 07/24/2013 | CN103214467A 5-[[4-[(2, 3-dimethyl-2H-indazole-6-yl) methylamino]-2-pyrimidyl] amino]-2-methyl-benzsulfamide derivative and preparation method and applications thereof |
| 07/24/2013 | CN103214456A Benzimidazole compound with antitumour activity as well as preparation method and application thereof |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214445A Preparation method and use of quercetin amide derivative |
| 07/24/2013 | CN103214444A Flavone sulphonamide derivative with anti-cancer activity as well as preparation method and application thereof |
| 07/24/2013 | CN103214441A Resveratrol dimer derivative as well as preparation and application method thereof |
| 07/24/2013 | CN103214431A 2,3-dihydrobenzazapine*compound or its salt and its medical application |
| 07/24/2013 | CN103214422A Preparation methods and anti-cancer effect of novel substituted amido imidazolone derivatives |
| 07/24/2013 | CN103214409A Synthesis of tetracyclines and analogues thereof |
| 07/24/2013 | CN103214370A 1, 6-O-dicaffeoyl sorbitol ester as well as derivative thereof and application |
| 07/24/2013 | CN103212093A Magnetic nano-grade material with cell-targeting property, and biomedical application thereof |
| 07/24/2013 | CN103212090A Application of microvesicle containing TGF (transforming growth factor)-beta1 siRNA (small interfering Ribonucleic Acid) |
| 07/24/2013 | CN103212089A Preparation method and application of carbon nanomaterial-immunostimulatory sequence compound |
| 07/24/2013 | CN103212087A Antibiotic-chitosan covalent conjugate and preparation method and application thereof in preparation of anti-tumor medicines |
| 07/24/2013 | CN103212086A Podophyllotoxin nano prodrug with high drug loading capacity and preparation method and application thereof |
| 07/24/2013 | CN103212083A Method for preparing stable albumin nano-particles |
| 07/24/2013 | CN103212082A Novel load method of camptothecin anti-cancer drug |
| 07/24/2013 | CN103212080A Nano composition having cancer prevention and treatment effects and preparation method |
| 07/24/2013 | CN103212077A Application of Erbin inhibitor in preparation of antitumor drug |
| 07/24/2013 | CN103212074A Preparation method of photosensitizer-doped nanoparticles with fluorescence resonance energy transfer and antenna effects and used for photodynamic therapy |
| 07/24/2013 | CN103212073A Coumarins and up-conversion rear earth nano-composite, and preparation method and application thereof |
| 07/24/2013 | CN103212072A An antigen associated with lung cancers and lymphomas |
| 07/24/2013 | CN103212071A Stem cell fusion model of carcinogenesis |
| 07/24/2013 | CN103212061A Application of free fatty acid receptor 2 in antitumor drugs |
| 07/24/2013 | CN103212056A Preparation based on gold, silver, gold-silver mixture and glutathione/chitosan, and application of preparation |
| 07/24/2013 | CN103212055A Drug composition of bortezomib and preparation method thereof |
| 07/24/2013 | CN103212002A Medicine for treating liver cancer and preparation method thereof |
| 07/24/2013 | CN103211910A Detoxifying and lipid reducing capsules and preparation method thereof |
| 07/24/2013 | CN103211898A Traditional Chinese medicine extractive and preparation method thereof |
| 07/24/2013 | CN103211887A Traditional Chinese medicine preparation for treating lipomatosis |
| 07/24/2013 | CN103211854A Blueberry leaf extract with melanin synthesis inhibitory activity |
| 07/24/2013 | CN103211853A Blueberry leaves extract with polyphenol oxidase inhibitory activity |
| 07/24/2013 | CN103211839A Application of stem-cell-derived microvesicles (MVs) in preparing medicine used in damaged or injured tissue or organ endothelial/epithelial regeneration, and related in-vitro and in-vivo methods |
| 07/24/2013 | CN103211837A Application of arsenic trioxide in preparation of medicines for treating renal carcinoma |
| 07/24/2013 | CN103211825A Novel celecoxib composition and preparation process thereof |
| 07/24/2013 | CN103211821A Drugs and uses |
| 07/24/2013 | CN103211820A Method for preparing tegafur, gimeracil and oteracil potassium capsules |
| 07/24/2013 | CN103211817A Uses of neurokinin receptor antagonist saredutant in liver cancer treatment |
| 07/24/2013 | CN103211781A Etoposide soft capsule |
| 07/24/2013 | CN103211775A Dispersible tablet |
| 07/24/2013 | CN103211773A Method for preparing leuprolide acetate microspheres |
| 07/24/2013 | CN103211772A Etoposide lyophilized powder for injection |
| 07/24/2013 | CN103211766A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/24/2013 | CN103211761A Seabuckthorn seed oil oral emulsion with gastric mucosa protective effect and preparation method and use thereof |
| 07/24/2013 | CN103211732A Preparation method and application of mixture with tyrosinase inhibitory activity |
| 07/24/2013 | CN102772385B Stable tretinoin tablets and preparation method thereof |
| 07/24/2013 | CN102617435B Leucosceptrum canum chinone, preparation method and application |
| 07/24/2013 | CN102614196B Application of phenylacetyl fluorobenzene salicylamide compound in preparation of anti-breast-cancer medicines |
| 07/24/2013 | CN102585004B AEG-1 (Astrocyte Elevated Gene-1)/1E3 monoclonal antibody with high affinity |
| 07/24/2013 | CN102526667B Loquat leaf/ginger composition for reducing vomiting due to cancer chemotherapy and enhancing effect of cancer chemotherapy, and preparation method thereof |
| 07/24/2013 | CN102488655B N3-ortho toluene formoxyl uracil nanosuspension and lyophilized preparation thereof |
| 07/24/2013 | CN102416181B Biodegradable high-polymer bonded photoactive Pt (IV) anticancer medicament micelle and preparation method thereof |
| 07/24/2013 | CN102379905B Ganoderma lucidum spore oil-containing Chinese medicinal composition with efficient cancer resistance |
| 07/24/2013 | CN102336740B Novel imidazole compound and its application |
| 07/24/2013 | CN102268454B Prostate specific membrane antigen (PSMA) recombinant adeno-associated virus vector and its construction method and use |
| 07/24/2013 | CN102249987B Combretastatin compound and preparation method and application thereof |
| 07/24/2013 | CN102219751B Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof |
| 07/24/2013 | CN102188370B Resveratrol injection solution and intravenous injection |
| 07/24/2013 | CN102153564B Nitrogen-atom-containing arteannuin dimers, and preparation method and application thereof |
| 07/24/2013 | CN102133217B Applications of pyridazinones compound taking N as bridged bond in preparation of medicine for resisting tumor |
| 07/24/2013 | CN102120036B Nano micelle of biodegradable macromolecular-bonding Pt(IV) anti-cancer medicament and preparation method thereof |
| 07/24/2013 | CN102058560B Dihydromyricetin soft capsules and preparation method thereof |
| 07/24/2013 | CN101925351B Cytostatic composition |
| 07/24/2013 | CN101885722B Heterocycle alkyne and benzene compound, medicinal composition and application thereof |
| 07/24/2013 | CN101817787B Androgen receptor antagonist for resisting prostate cancer |
| 07/24/2013 | CN101723930B Shikimic acid compound and preparation method and application thereof |
| 07/24/2013 | CN101688205B Anti-tumor drug, medicament, composition, and use thereof |
| 07/24/2013 | CN101669900B Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/24/2013 | CN101663302B Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 07/24/2013 | CN101613386B Gambogic acid cyclized analog, preparation method and application thereof |
| 07/24/2013 | CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 07/24/2013 | CN101370519B Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer |
| 07/24/2013 | CN101128199B Monocyclic heterocycles as kinase inhibitors |
| 07/23/2013 | US8492613 GNTIII expression in plants |
| 07/23/2013 | US8492570 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492383 Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia |
| 07/23/2013 | US8492374 Azaazulene compounds |
| 07/23/2013 | US8492345 Cyclic peptide antitumor agents |
| 07/23/2013 | US8492344 PDK inhibitor compounds and methods of use thereof |
| 07/23/2013 | US8492343 Protein scaffold library based on kringle domain structure and uses thereof |
| 07/23/2013 | US8492342 Preprocalcitonin antigen T epitopes |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | CA2642943C Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs |
| 07/23/2013 | CA2635392C New pyrrolic derivatives with histone deacetylase inhibitory activity |
| 07/23/2013 | CA2630334C Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer |
| 07/23/2013 | CA2606716C Use of pyrimidylaminobenzamide derivatives for the treatment of systematic mastocytosis |
| 07/23/2013 | CA2596634C Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostatic hyperplasia, prostate carcinoma and spinobulbar muscular atrophy |